Core Viewpoint - Permian Resources Corporation has announced the pricing of a public offering of 46,112,899 shares of its Class A Common Stock at a price of $13.53 per share, with the offering being conducted by certain affiliates of Pearl Energy Investments and Riverstone Investment Group LLC [1] Group 1 - The total number of shares being offered is 46,112,899 [1] - The price per share for the public offering is set at $13.53 [1] - The offering is being made by selling stockholders, specifically affiliates of Pearl Energy Investments and Riverstone Investment Group LLC [1]

Group 1 - Permian Resources Corporation has announced the commencement of an underwritten public offering of 46,112,899 shares of its Class A Common Stock [1] - The offering is being conducted by certain affiliates of Pearl Energy Investments and Riverstone Investment Group LLC, referred to as the Selling Stockholders [1] - Permian Resources will not sell any shares of Class A common stock in this offering [1]

Core Viewpoint - Evolent Health, Inc. has announced the pricing of $145.0 million in 4.50% convertible senior notes due 2031, aimed at improving financial flexibility and reducing interest expenses while minimizing shareholder dilution [1][2][5]. Group 1: Transaction Details - The offering size was increased from $140.0 million to $145.0 million, with an additional option for initial purchasers to buy up to $21.75 million more [1]. - Evolent expects net proceeds of approximately $140.2 million, or $161.2 million if the additional notes option is fully exercised, which will be used primarily to repurchase existing convertible senior notes [5][7]. - The notes will mature on August 15, 2031, and interest will be paid semiannually at a rate of 4.50% [6]. Group 2: Conversion and Repurchase Terms - The notes are convertible at the option of the holders prior to maturity, with an initial conversion price of approximately $13.53 per share, representing a 50% premium over the closing price on August 18, 2025 [6]. - Evolent may terminate conversion rights under certain conditions related to the stock price performance [3]. - Holders can require Evolent to repurchase their notes upon a "fundamental change" at 100% of the principal amount plus accrued interest [4]. Group 3: Share Repurchase Impact - Evolent plans to repurchase approximately 4.43 million shares of its Class A common stock at a price of $9.02 per share, which may influence the market price of both the stock and the notes [8][9]. - The repurchase of shares sold short by initial investors could lead to increased market activity affecting the stock price [9]. Group 4: Company Overview - Evolent Health specializes in improving health outcomes for individuals with complex conditions and serves a national base of leading payers and providers [13].

Core Viewpoint - Snail, Inc. has entered into an At The Market Offering Agreement to sell up to $4,500,000 of its Class A Common Stock to support its digital asset initiative, including the potential introduction of a proprietary stablecoin backed by U.S. dollars [1][2]. Group 1: Offering Details - The Offering will be conducted under a Sales Agreement with H.C. Wainwright & Co. as the sales agent, allowing the company to sell shares from time to time in an at the market offering [1][3]. - The shares will be sold through methods permitted by law, including direct sales on the Nasdaq Capital Market [3]. - The Offering will be made only by means of a prospectus supplement filed with the SEC, which is part of the company's shelf registration statement [4]. Group 2: Use of Proceeds - The net proceeds from the sale of the shares will primarily be used for working capital to support the company's digital asset initiative, including the evaluation of a proprietary stablecoin [2]. Group 3: Company Overview - Snail, Inc. is a leading global independent developer and publisher of interactive digital entertainment, with a portfolio of premium games for various platforms [6].

Core Viewpoint - Hycroft Mining Holding Corporation successfully exercised the underwriters' over-allotment option, resulting in additional capital to support exploration and development activities at the Hycroft Mine [1][4]. Group 1: Offering Details - The underwriters' over-allotment option included the purchase of an additional 1,324,117 shares of Class A Common Stock at $3.49 per share and 937,500 warrants at $0.02 per warrant [1][2]. - The total number of Class A Common Stock sold in the public offering increased to 13,824,117 shares, with total warrants issued rising to 7,187,500 [3]. - Gross proceeds from the offering reached approximately $48.4 million before deducting underwriting discounts and offering expenses [3]. Group 2: Use of Proceeds - The net proceeds from the offering will be utilized for further exploration, working capital, and general corporate purposes [4]. Group 3: Company Background - Hycroft Mining Holding Corporation is focused on developing the Hycroft Mine, one of the largest precious metals deposits in northern Nevada, and is transitioning to commercial operations for processing sulfide ore [7]. - The company is also engaged in a robust exploration drill program to expand high-grade silver systems and unlock the full potential of its mining assets [7].